The Interaction between the Akt pathway, ferroptosis, and immunotherapy in HCC demonstrates promising avenues for therapeutic interventions, particularly through combined targeting of these pathways to enhance treatment efficacy and patient survival (Zheng et al., 2023). The gene discussed is AKT1; the disease is hepatocellular carcinoma.